Nourish Raises $100M Series C as Investors Eye Post-GLP-1 Plays Nourish, a telehealth platform that pairs patients with registered dietitians, comes as more people take weight-loss drugs but struggle with what comes next Nourish, a New York-based virtual nutrition clinic, has closed a $100 million Series C led by Menlo Ventures, bringing total funding to $215 million in just over four years
These labs include an obesity lab panel, which measures CBC (blood count), CMP (metabolic function), lipids (cholesterol levels), A1C (diabetes), TSH (thyroid function), and insulin
At the highest dose, 16% of participants taking the triple agonist had to discontinue the drug due to gastrointestinal side-effects
The Energize Plus Pure Pack is specifically formulated with bioavailability as the primary focus
"Its also important to remember that starting a GLP-1 medication is not a substitute for taking care of overall health